NCT06731842View on ClinicalTrials.gov

Molecular PET Imaging and Plasma Biomarkers in Alzheimer´s Disease and Other Neurodegenerative Diseases

NAEnrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 15, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Alzheimer´s Disease
Interventions
OTHER

18F-RO948

Tau PET imaging using the tau PET tracer 18F-RO948 in famial and sporadic Alzheimer´s disease

Trial Locations (1)

141 52

Karolinska institutet NVS, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER